Medical Digest & Congress Report

Professor Juan J. Badimon discusses the SOTA-P-CARDIA Trial, a randomized trial of sotagliflozin in HFpEF patients without diabetes, presented at AHA Scientific Sessions 2025.

Video: https://medicaldigest.org/scientific-contents/interview:sota-p-cardia-trial-randomized-trial-sotagliflozin-hfpef-patients-without-diabetes

Professor Matthew Tomey discusses the clinicians view on the2025 Guideline for Acute Coronary Syndromes at AHA Scientific Sessions 2025.

Video: https://medicaldigest.org/scientific-contents/interview:clinicians-view-2025-guideline-acute-coronary-syndromes

Professor Tiziana Claudia Aranzulla shares her insights on the Guideline for Acute Coronary Syndromes from the European perspective at AHA Scientific Sessions 2025.

Video: https://medicaldigest.org/scientific-contents/interview:new-2025-guideline-acute-coronary-syndromes-european-perspective

Dr. Gregory Conn shares his insights on state of the art tumor-targeting IL-12 immunocytokine therapies after SITC's 40th Anniversary Annual Meeting.

Video: https://medicaldigest.org/scientific-contents/interview:state-art-tumor-targeting-il-12-immunocytokine-therapies

Professor Jianjun Zhang shares his insights on reprogramming the immune microenvironment to intercept lung adenocarcinoma precancer at SITC's 40th Anniversary Annual Meeting.

Video: https://medicaldigest.org/scientific-contents/interview:reprogramming-immune-microenvironment-intercept-lung-adenocarcinoma-precancer

Professor Gino In presented data from the NeoPOWER trial, to study the role of neoadjuvant PD-1 alone in CSCC at SITC's 40th Anniversary Annual Meeting.

Video: https://medicaldigest.org/scientific-contents/interview:primary-analysis-patients-high-risk-localized-locally-recurrent-or-regionally-advanced-cutaneous-squamous-cell-carcinoma-treated-neoadjuvant-pd-1-therapy

Professor William Decker discusses the Phase I Trial of DOC1021 cell-based immunotherapy for resectable or borderline resectable pancreatic ductal adenocarcinoma at SITC's 40th Anniversary Annual Meeting.

Video: https://medicaldigest.org/scientific-contents/interview:phase-i-trial-doc1021-cell-based-immunotherapy-resectable-or-borderline-resectable-pancreatic-ductal-adenocarcinoma

Professor Gordon J. Freeman shares his insights on how to optimize PD1/PDL1 treatment at SITC's 40th Anniversary Annual Meeting.

Video: https://medicaldigest.org/scientific-contents/interview:how-optimize-pd1pdl1-treatment

Professor Sumit K. Subudhi shares his insights on modulating the tumor microenvironment with T Cell bispecifics at SITC's 40th Anniversary Annual Meeting.

Video: https://medicaldigest.org/scientific-contents/interview:modulating-tumor-microenvironment-t-cell-bispecifics

Dr. Saud Alawad and Prof. Sunil Sharma discuss the comparative cardioprotective effects of GLP-1 receptor agonists versus SGLT2 inhibitors in pulmonary arterial hypertension after the American College of Chest Physicians (CHEST) 2025 Annual Meeting.

Video: https://medicaldigest.org/scientific-contents/interview:comparative-cardioprotective-effects-glp-1-receptor-agonists-versus-sglt2-inhibitors-pulmonary-arterial-hypertension-insights-large-scale-real-world-data-analysis